Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Allergy Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Allergy Other
    ERRATUM: Pretreatment With Omalizumab Can Safely Increase Effectiveness of Immunotherapy: Presented at ACAAI - (DGDispatch)
    Antibodies to Cockroach, Mouse Proteins Associated With Asthma and Allergies in Preschool Children - (DGNews)
    Desloratadine May Have Early Effect on Nasal Congestion, Other Symptoms of Persistent Allergic Rhinitis: Presented at ACAAI - (DGDispatch)
    Fluticasone Provides Better Relief Than Fexofenadine for Nighttime Seasonal Allergy Symptoms: Presented at ACAAI - (DGDispatch)
    Grass Allergen Immunotherapy Tablet Can Reduce Need for Rescue Medication and Shorten Allergy Season: Presented at ACAAI - (DGDispatch)

    News archive

     Recent webcasts/CME - Allergy Other
    New Perspectives on Allergy Management: Ophthalmologists and Allergists Weigh in on Key Issues
    Food Allergies: When the Food Comes to Bite the Gut

    Webcasts/CME archive

     Recent cases - Allergy Other
      Allergic Enterocolitis and Protein-Losing Enteropathy as the Presentations of Manganese Leak From an Ingested Disk Battery: A Case Report
      Successful Desensitization with Human Insulin in a Patient with an Insulin Allergy and Hypersensitivity to Protamine: A Case Report
      Milk Allergy and Bottles Over the Back Fence: Two Single Patient Trials
      Patch Test Triggering Recurrence of Distant Dermatitis: The Flare-Up Phenomenon
      Pigeon Fanciers Lung: A Case Report

      Cases archive
        




      my personal edition > allergy other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Itraconazole Use Shows Promise in Chronic Sinusitis: Presented at EAACI

      By Jill Stein

      PARIS, FRANCE -- June 10, 2003 -- Selective use of itraconazole appears to be safe and effective in some chronic sinusitis patients, say researchers.

      This finding was announced at the 22nd Congress of the European Academy of Allergology and Clinical Immunology (EAACI) by Dr. Karl W. Baumgart, with Royal Prince Alfred Hospital Camperdown in Sydney, Australia. The study investigated 48 patients with persistent sinusitis, despite the use of conventional strategies, who were then treated with itraconazole, 100 mg bid for 3 months

      Conventional strategies included surgery to restore ostial patency; management of salicylate/aspirin sensitivity by diet modification, anti-histamine, and anti- leukotriene blockade, and aspirin avoidance or desensitisation.

      The decision to use an anti-fungal treatment in these patients was based on the recognition that fungal colonization may cause chronic sinusitis. Overall, 32 (66%) patients had a significant improvement in symptoms, and benefit was evident as early as 3 to 6 weeks after the start of treatment.


      Itraconazole treatment was safe and well tolerated, although 2 patients complained of weight gain. Four patients did deteriorate during treatment and were subsequently referred for functional endoscopic sinus surgery during treatment.


      Dr. Baumgart said that prospective randomised, clinical trials may be useful for determining whether itraconazole treatment in parallel with initial surgery might reduce the need for repeat surgery or perhaps eliminate the need for surgery altogether. Studies are also needed to identify which patients are most likely to benefit and what is the optimal duration for treatment.

      At present, the researchers treat chronic sinusitis patients who have failed standard treatments with itraconazole, 100 mg bid for 3 months, followed by an additional 3 months of itraconazole, 100 mg once daily.

      Finally, he emphasized that itraconazole treatment should be used only as a "rescue remedy" in patients who have persistent disease despite the "valiant" efforts of ear, nose, and throat surgeons and the use of all other standard measures.



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send